β-Amyloid pathogenesis: Chemical properties versus cellular levels

Alzheimer's and Dementia

Volumn 12, Issue 2, 2016, Pages 184-194

  Tiwari, Manish K ^a   Kepp, Kasper P ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Aggregation; Alzheimer's disease; Amyloid levels; Meta analysis; Phenotype; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID;

BINDING SITE; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYDROPHOBICITY; METAL BINDING; MISSENSE MUTATION; NEUROPATHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; REVIEW; VASCULAR AMYLOIDOSIS; ALZHEIMER DISEASE; CHEMISTRY; META ANALYSIS; METABOLISM; ONSET AGE; PATHOLOGY; PROTEIN CONFORMATION;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; HUMANS; PROTEIN CONFORMATION;

EID: 84957838365     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.06.1895     Document Type: Article

References (58)

1. J. Karlawish Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease Neurology 77 2011 1487 1493
2. K.P. Kepp Bioinorganic chemistry of Alzheimer's disease Chem Rev 112 2012 5193 5239
3. S. Karantzoulis, and J.E. Galvin Distinguishing Alzheimer's disease from other major forms of dementia Expert Rev Neurother 11 2011 1579 1591
4. B. Schneider, D. Prvulovic, V. Oertel-Knochel, C. Knochel, B. Reinke, M. Grexa, and et al. Biomarkers for major depression and its delineation from neurodegenerative disorders Prog Neurobiol 95 2011 703 717
5. G.A. Higgins Introduction: Should a unified nomenclature be adopted for the amyloid protein of Alzheimer's disease? Neurobiol Aging 11 1990 61 62
6. J.D. Sipe, M.D. Benson, J.N. Buxbaum, S. Ikeda, G. Merlini, M.J. Saraiva, and et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis Amyloid 17 2010 101 104
7. S. Weggen, and D. Beher Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease Alzheimers Res Ther 4 2012 9
8. E. Levy-Lahad, W. Wasco, P. Poorkaj, D.M. Romano, J. Oshima, W.H. Pettingell, and et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus Science 269 1995 973 977
9. L. Serneels, T. Dejaegere, K. Craessaerts, K. Horre, E. Jorissen, T. Tousseyn, and et al. Differential contribution of the three Aph1 genes to γ-secretase activity in vivo Proc Natl Acad Sci U S A 102 2005 1719 1724
10. L. Chávez-Gutiérrez, L. Bammens, I. Benilova, A. Vandersteen, M. Benurwar, M. Borgers, and et al. The mechanism of γ-secretase dysfunction in familial Alzheimer disease EMBO J 31 2012 2261 2274
11. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics Nat Rev Drug Discov 10 2011 698 712
12. C. Reitz Alzheimer's disease and the amyloid cascade hypothesis: A critical review Int J Alzheimers Dis 2012 2012 369808
13. J.A. Hardy, and G.A. Higgins Alzheimer's disease: The amyloid cascade hypothesis Science 256 1992 184 185
14. S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, and et al. A specific amyloid-β protein assembly in the brain impairs memory Nature 440 2006 352 357
15. K. Ono, M.M. Condron, and D.B. Teplow Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc Natl Acad Sci U S A 106 2009 14745 14750
16. A. Lorenzo, and B.A. Yankner β- amyloid neurotoxicity requires fibril formation and is inhibited by congo red Proc Natl Acad Sci U S A 91 1994 12243 12247
17. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid β-peptide Nat Rev Mol Cell Biol 8 2007 101 112
18. A. Rauk The chemistry of Alzheimer's disease Chem Soc Rev 38 2009 2698 2715
19. W.I. Rosenblum Why Alzheimer trials fail: Removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult Neurobiol Aging 35 2014 969 974
20. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, C. Forsell, and et al. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat Neurosci 4 2001 887 893
21. T. Jonsson, J.K. Atwal, S. Steinberg, J. Snaedal, P.V. Jonsson, S. Bjornsson, and et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline Nature 488 2012 96 99
22. G. Di Fede, M. Catania, M. Morbin, G. Rossi, S. Suardi, G. Mazzoleni, and et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis Science 323 2009 1473 1477
23. K. Ono, M.M. Condron, and D.B. Teplow Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity J Biol Chem 285 2010 23186 23197
24. Y. Hori, T. Hashimoto, Y. Wakutani, K. Urakami, K. Nakashima, M.M. Condron, and et al. The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate Aβ fibril formation without increasing protofibril formation J Biol Chem 282 2007 4916 4923
25. W.T. Chen, C.J. Hong, Y.T. Lin, W.H. Chang, H.T. Huang, J.Y. Liao, and et al. Amyloid-beta (Aβ) D7H mutation increases oligomeric Aβ42 and alters properties of Aβ-zinc/copper assemblies PLoS One 7 2012 e35807
26. L. Zhou, N. Brouwers, I. Benilova, A. Vandersteen, M. Mercken, K. Van Laere, and et al. Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β'-site increases Aβ generation EMBO Mol Med 3 2011 291 302
27. D. Kaden, A. Harmeier, C. Weise, L.M. Munter, V. Althoff, B.R. Rost, and et al. Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers EMBO Mol Med 4 2012 647 659
28. W.E. Van Nostrand, J.P. Melchor, H.S. Cho, S.M. Greenberg, and G.W. Rebeck Pathogenic effects of D23N Iowa mutant amyloid β-protein J Biol Chem 276 2001 32860 32866
29. L. Miravalle, T. Tokuda, R. Chiarle, G. Giaccone, O. Bugiani, F. Tagliavini, and et al. Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells J Biol Chem 275 2000 27110 27116
30. T. Tomiyama, T. Nagata, H. Shimada, R. Teraoka, A. Fukushima, H. Kanemitsu, and et al. A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia Ann Neurol 63 2008 377 387
31. L. Obici, A. Demarchi, G. de Rosa, V. Bellotti, S. Marciano, S. Donadei, and et al. A novel AβPP mutation exclusively associated with cerebral amyloid angiopathy Ann Neurol 58 2005 639 644
32. D.A. Carter, E. Desmarais, M. Bellis, D. Campion, F. Clerget-Darpoux, A. Brice, and et al. More missense in amyloid gene Nat Genet 2 1992 255 256
33. C.T. Jones, S. Morris, C.M. Yates, A. Moffoot, C. Sharpe, D.J. Brock, and et al. Mutation in codon 713 of the β amyloid precursor protein gene presenting with schizophrenia Nat Genet 1 1992 306 309
34. K. Murakami, K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, and et al. Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease J Biol Chem 278 2003 46179 46187
35. V. Betts, M.A. Leissring, G. Dolios, R. Wang, D.J. Selkoe, and D.M. Walsh Aggregation and catabolism of disease-associated intra-Aβ mutations: Reduced proteolysis of AβA21G by neprilysin Neurobiol Dis 31 2008 442 450
36. Y. Tomidokoro, A. Rostagno, T.A. Neubert, Y. Lu, G.W. Rebeck, B. Frangione, and et al. Iowa variant of familial Alzheimer's disease: Accumulation of posttranslationally modified AβD23N in parenchymal and cerebrovascular amyloid deposits Am J Pathol 176 2010 1841 1854
37. E. Portelius, N. Bogdanovic, M.K. Gustavsson, I. Volkmann, G. Brinkmalm, H. Zetterberg, and et al. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease Acta Neuropathol 120 2010 185 193
38. J. Wang, D.W. Dickson, J.Q. Trojanowski, and V.M. Lee The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging Exp Neurol 158 1999 328 337
39. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, and et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am J Pathol 155 1999 853 862
40. C. Holmes Genotype and phenotype in Alzheimer's disease Br J Psychiatry 180 2002 131 134
41. C. Haass, C.A. Lemere, A. Capell, M. Citron, P. Seubert, D. Schenk, and et al. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway Nat Med 1 1995 1291 1296
42. O. Hansson, H. Zetterberg, P. Buchhave, U. Andreasson, E. Londos, L. Minthon, and et al. Prediction of Alzheimer's disease using the CSF Aβ42/Aβ40 ratio in patients with mild cognitive impairment Dement Geriatr Cogn Disord 23 2007 316 320
43. I. Dolev, H. Fogel, H. Milshtein, Y. Berdichevsky, N. Lipstein, N. Brose, and et al. Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change Nat Neurosci 16 2013 587 595
44. J. Carter, and C.F. Lippa β-amyloid, neuronal death and Alzheimer's disease Curr Mol Med 1 2001 733 737
45. W. Qiang, W.M. Yau, Y. Luo, M.P. Mattson, and R. Tycko Antiparallel β-sheet architecture in Iowa-mutant β-amyloid fibrils Proc Natl Acad Sci U S A 109 2012 4443 4448
46. A. Lomakin, D.B. Teplow, D.A. Kirschner, and G.B. Benedek Kinetic theory of fibrillogenesis of amyloid β-protein Proc Natl Acad Sci U S A 94 1997 7942 7947
47. D. Galasko, L. Chang, R. Motter, C.M. Clark, J. Kaye, D. Knopman, and et al. High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype Arch Neurol 55 1998 937 945
48. F.M. LaFerla, K.N. Green, and S. Oddo Intracellular amyloid-β in Alzheimer's disease Nat Rev Neurosci 8 2007 499 509
49. D.K. Lahiri, and B. Maloney Beyond the signaling effect role of amyloid-ss42 on the processing of APP, and its clinical implications Exp Neurol 225 2010 51 54
50. T. Lu, Y. Pan, S.Y. Kao, C. Li, I. Kohane, J. Chan, and et al. Gene regulation and DNA damage in the ageing human brain Nature 429 2004 883 891
51. M.K. Tiwari, and K.P. Kepp Pathogenic properties of Alzheimer's β-amyloid identified from structure-property patient-phenotype correlations Dalton Trans 44 2015 2747 2754
52. T.A. Bayer, and O. Wirths Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease Acta Neuropathol 127 2014 787 801
53. S. Jawhar, O. Wirths, and T.A. Bayer Pyroglutamate amyloid-beta (Abeta): A hatchet man in Alzheimer disease J Biol Chem 286 2011 38825 38832
54. K.J. Barnham, and A.I. Bush Metals in Alzheimer's and Parkinson's diseases Curr Opin Chem Biol 12 2008 222 228
55. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, and et al. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
56. M.A. Lovell A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease J Alzheimers Dis 16 2009 471 483
57. S. Vivekanandan, J.R. Brender, S.Y. Lee, and A. Ramamoorthy A partially folded structure of amyloid-beta(1-40) in an aqueous environment Biochem Biophys Res Commun 411 2011 312 316
58. Accelrys Discovery Studio Modeling Environment, Release 4.0 2013 Accelrys Software Inc. San Diego